GBLX — GB Sciences Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Gb Sciences Inc - Reported Positive Results From A Study Of Its Potential Treatment For Cytokine Release Syndrome
Brief: GB Sciences Sells Its Louisiana Medical Marijuana Business
Brief: GB Sciences Files Novel Patent Application
Brief: GB Sciences Announces The Appointment Of John Davis As Executive VP And General Counsel
Brief: GB Sciences Pursues FDA-Registered, First-In-Human Trial Of Cannabis Based Therapy For Parkinson's Disease
White House may boost recreational marijuana enforcement -spokesman (updated)